News
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...
The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, ...
Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...
Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company ...
A nonprofit controlled by Anne Wojcicki, former chief executive of 23andMe ... 23andMe, which helped popularize at-home DNA test kits and was once valued at $6 billion, declared Chapter 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results